Ken O'Flynn

1012. Deputy Ken O'Flynn asked the Minister for Children, Disability and Equality whether she will provide the ten private residential childcare placement providers that received the highest level of Tusla expenditure in 2024, together with the total amount paid to each provider. [39863/26]

1013. Deputy Ken O'Flynn asked the Minister for Children, Disability and Equality the total amount spent by Tusla on private residential childcare placements in each of the past ten years. [39864/26]

1014. Deputy Ken O'Flynn asked the Minister for Children, Disability and Equality the percentage increase in Tusla expenditure on private residential childcare placements between 2020 and 2025. [39865/26]

1015. Deputy Ken O'Flynn asked the Minister for Children, Disability and Equality whether Tusla applies national pricing ceilings, benchmark rates, or value-for-money assessments when procuring private residential childcare placements. [39866/26]

1016. Deputy Ken O'Flynn asked the Minister for Children, Disability and Equality whether Tusla conducts comparative cost analysis between State-operated and privately operated residential childcare placements. [39867/26]

1017. Deputy Ken O'Flynn asked the Minister for Children, Disability and Equality whether Tusla records average weekly costs per child by private residential childcare provider. [39868/26]

1018. Deputy Ken O'Flynn asked the Minister for Children, Disability and Equality whether Tusla has identified any risks associated with market concentration or dependency on a small number of private residential childcare providers. [39869/26]

1019. Deputy Ken O'Flynn asked the Minister for Children, Disability and Equality whether Tusla publishes or intends to publish a central register of private residential childcare providers receiving public funding, including annual payments received. [39870/26]

1040. Deputy Ken O'Flynn asked the Minister for Children, Disability and Equality whether the Department receives routine reports on Children’s Disability Network Team vacancy duration, staffing deficits, or delayed intervention risks. [40103/26]

1111. Deputy Ken O'Flynn asked the Minister for Health whether her Department or the HSE has carried out any national assessment since 2020 of the annual cost to the Exchequer of unused, expired, uncollected, or otherwise wasted medicines under State-funded medicine schemes; and if she will publish any such assessment. [38763/26]

1112. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records the quantity and estimated value of unused or expired medicines returned to community pharmacies under State-funded medicine schemes; and if not, whether she intends to establish such a reporting mechanism. [38764/26]

1113. Deputy Ken O'Flynn asked the Minister for Health what policy measures are currently in place to reduce avoidable medicines waste under the GMS, DPS, LTI and other community drug schemes. [38765/26]

1114. Deputy Ken O'Flynn asked the Minister for Health whether his Department has examined the role of repeat prescribing, automatic renewals, phased dispensing, blister-pack changes, and non-adherence in contributing to medicines waste; and whether any reform proposals are under consideration. [38766/26]

1115. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has a national medicines waste reduction strategy; and if not, whether one will be developed in light of recent research estimating annual medicines waste at over €37.5 million. [38767/26]

1116. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has estimated the environmental impact of unused or expired medicines, including disposal, incineration, contamination risk, and pharmaceutical residues entering water systems. [38768/26]

1117. Deputy Ken O'Flynn asked the Minister for Health when the proposed national scheme for safe disposal of unused medicines will be introduced; what funding has been allocated; whether it will involve community pharmacies; and whether it will operate nationally. [38769/26]

1118. Deputy Ken O'Flynn asked the Minister for Health whether the HSE reimburses medicines which are dispensed but never collected by patients; what safeguards exist to prevent unnecessary reimbursement; and whether data on uncollected medicines is centrally collected. [38770/26]

1119. Deputy Ken O'Flynn asked the Minister for Health whether medication reviews for patients on multiple prescriptions are being used systematically to reduce over-prescribing, duplication, and avoidable waste; and what targets or KPIs apply. [38771/26]

1120. Deputy Ken O'Flynn asked the Minister for Health whether his Department has assessed potential savings from reducing medicines waste by 10%, 20% or 30%; and whether such savings have been modelled for reinvestment in frontline pharmacy or prescribing services. [38772/26]

1128. Deputy Ken O'Flynn asked the Minister for Health whether any HSE national policy, clinical guideline, serious incident framework, or safety protocol explicitly references signs of life following termination of pregnancy. [38839/26]

1129. Deputy Ken O'Flynn asked the Minister for Health whether any hospital is required to notify the HSE National Incident Management Team where signs of life are observed following termination of pregnancy. [38840/26]

1130. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has classified any such event as a serious reportable event, serious incident, or notifiable patient safety incident since 2019. [38841/26]

1131. Deputy Ken O'Flynn asked the Minister for Health whether her Department has sought legal advice regarding statutory reporting obligations in such cases. [38842/26]

1132. Deputy Ken O'Flynn asked the Minister for Health whether HIQA has any inspection, governance, or oversight role in relation to such incidents. [38843/26]

1134. Deputy Ken O'Flynn asked the Minister for Health the division of the HSE or Department of Health that holds responsibility for estimating the number of patients clinically eligible for orphan medicinal products approved for reimbursement in the State (details supplied). [38846/26]